Zhang, Xin <br/><br/>
Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma.  [electronic resource] 

 -  Oncogene  06 2020 
 - 4770-4779 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5594 
<br/><br/><label>Standard No.: </label>10.1038/s41388-020-1301-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--chemistry<br/>Carcinoma, Squamous Cell--drug therapy<br/>Cell Line, Tumor<br/>Drug Delivery Systems<br/>Heterocyclic Compounds, 4 or More Rings--chemistry<br/>Humans<br/>Nuclear Proteins--genetics<br/>Oncogene Proteins, Fusion--genetics<br/>Peptide Fragments--antagonists & inhibitors<br/>Protein Domains<br/>Proto-Oncogene Proteins c-myc--genetics<br/>Sialoglycoproteins--antagonists & inhibitors<br/>Transcription Factors--genetics<br/>Tumor Suppressor Proteins--genetics